Indivior Reaches $102.5 Million Multi-State Settlement of Suboxone-Related Antitrust Claims
- June 09, 2023
Indivior would pay 41 states and the District of Columbia $102.5 million to resolve multi-district antitrust litigation against the company involving its opioid addiction treatment drug Suboxone under a settlement agreement announced June 2.
ARTICLE TAGS
You must be logged in to access this content.